Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kanematsu Corporation is a prominent Japanese general trading company (sogo shosha) with a robust presence in the life sciences and healthcare sectors. The company's Medical & Healthcare division focuses on the global distribution of active pharmaceutical ingredients (APIs), intermediates, and advanced medical devices. Kanematsu acts as a vital bridge in the healthcare supply chain, facilitating the entry of innovative medical technologies and diagnostic equipment into the Japanese market. Through its subsidiary, Kanematsu Chemicals, the firm provides specialized support for pharmaceutical manufacturing and chemical distribution. Additionally, Kanematsu is expanding its footprint in digital health and medical technology investments to address evolving healthcare needs. The company leverages its extensive global network to provide comprehensive logistics and commercialization services for the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kanematsu.